+1-888-308-5802     
News Contact Us

Pneumonia Therapeutics Market 2020 By Revenue, Top Trend & Regional Growth Forecast

Author : Ronak Bora | Published Date : 2020-09-02 

Pneumonia Therapeutics Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

The global pneumonia therapeutics industry is slated to observe substantial growth due to the rising incidents of pneumococcal disease as well as increasing regulatory initiatives for pneumonia treatment. Pneumonia is a critical respiratory disease that annually affects a considerable number of the global population. An upsurge in the number calls for effective treatment for this disease is thereby fueling the market size. In addition, the increasing global population, along with its rising demographic of individuals aged 65 and above as well as children aged two and below, are likely to increase yearly cases. The geriatric population is highly susceptible to this disease since their immune systems are relatively weak and effectively cannot tackle the infection on its own.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2029

According to a research report by GMI Inc., the global pneumonia therapeutics market is likely to surpass a valuation of $2.8 billion by 2026.

With reference to drug class, the antibacterial drugs segment held the highest revenue share, representing more than 60% of the overall revenue share in 2019. Antibacterial drugs are further bifurcated into quinolones and macrolides.

Both these drugs are generally used to treat pneumonia that is community-acquired. Moreover, macrolides antibiotics such as azithromycin, and clarithromycin are used exponentially to protect children from pneumonia, thereby driving the segment share.

From the perspective of age group, the pediatric age group is slated to account for momentous product deployment due to weak and underdeveloped immune systems of children. The underdeveloped immune systems make children more vulnerable to pneumonia, thereby driving the segment share. 

Additionally, children with asthma issues or cystic fibrosis, and other disorders related to lungs, increases their susceptibility to contract pneumonia, which is likely to augment the need for antibacterial as well as antiviral drugs. Based on these factors, the pediatric segment is estimated to expand at a CAGR of about 7.5% through the analysis period.

Geographically, the North America pneumonia therapeutics market is estimated to observe significant growth opportunities led by the U.S. In fact, the U.S. pneumonia therapeutics market is slated to record a CAGR of more than 6.3% through the forecast timeframe.

This regional growth can be ascribed to the country’s growing geriatric population, which is creating the demand for pneumonia medications. In addition, the surging number of hospital admissions to treat pneumonia is also likely to enhance the regional market expansion.

The regional industry is also slated to foresee a significant rate of proliferation due to the strong presence of prominent market players like Allergan, and Abbott Laboratories. These industry players are increasingly focusing towards product innovations and several R&D initiatives, which is likely to push the regional industry outlook.

The competitive landscape of the pneumonia therapeutics market is inclusive of players such as GlaxoSmithKline, AstraZeneca, Merck, Pfizer, Sanofi, Novartis, Mylan, Lupin Pharmaceuticals, Cipla, and Bayer among others. 

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/pneumonia-therapeutics-market

Partial Chapter of the Table of Content 

Chapter 4. Pneumonia Therapeutics Market, By Drug Class

4.1. Key segment trends

4.2. Antibacterial drugs

4.2.1.  Antibacterial drugs market, by region, 2015 - 2026, (USD Million)

4.2.2.  Macrolide

4.2.2.1.    Macrolide market, by region, 2015 - 2026, (USD Million)

4.2.3.  Quinolones

4.2.3.1.    Quinolones market, by region, 2015 - 2026, (USD Million)

4.2.4.  Others

4.2.4.1.    Others market, by region, 2015 - 2026, (USD Million)

4.3. Antiviral drugs

4.3.1.  Antiviral drugs market, by region, 2015 - 2026, (USD Million)

4.4. Antifungal drugs

4.4.1.  Antifungal drugs market, by region, 2015 - 2026, (USD Million)

Chapter 5. Pneumonia Therapeutics Market, By Age Group

5.1. Key segment trends

5.2. Pediatric

5.2.1.  Pediatric market by region, 2015 - 2026 (USD Million)

5.3. Adult

5.3.1.  Adult market, by region, 2015 - 2026, (USD Million)

5.4. Geriatric

5.4.1.  Geriatric market by region, 2015 - 2026 (USD Million)

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

Endoscopy Market 2020 growth factors, latest trend and regional analysis of leading players by 2024

Published Date: 2020-09-22         Author: Ronak Bora

Endoscopy Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges. ... Read More

Therapeutic Respiratory Devices Market 2020 By Revenue, Top Trend & Regional Growth Forecast

Published Date: 2020-09-22         Author: Ronak Bora

Therapeutic Respiratory Devices Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and i... Read More

Healthcare 3D Printing Market 2020 By Regional Trend & Growth Forecast To 2024

Published Date: 2020-09-22         Author: Ronak Bora

Healthcare 3D Printing Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry c... Read More

© 2020 Fractovia. All Rights Reserved